These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16166374)

  • 1. p53: link to the past, bridge to the future.
    Mills AA
    Genes Dev; 2005 Sep; 19(18):2091-9. PubMed ID: 16166374
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 isoforms can regulate p53 transcriptional activity.
    Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
    Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer.
    Okumura N; Yoshida H; Kitagishi Y; Nishimura Y; Matsuda S
    Biochem Biophys Res Commun; 2011 Sep; 413(3):395-9. PubMed ID: 21893034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continuing saga of p53--more sleepless nights ahead.
    Prives C; Manfredi JJ
    Mol Cell; 2005 Sep; 19(6):719-21. PubMed ID: 16168367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional control of the proliferation cluster by the tumor suppressor p53.
    Brosh R; Rotter V
    Mol Biosyst; 2010 Jan; 6(1):17-29. PubMed ID: 20024063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatively spliced isoforms of the human elk-1 mRNA within the 5' UTR: implications for ELK-1 expression.
    Araud T; Genolet R; Jaquier-Gubler P; Curran J
    Nucleic Acids Res; 2007; 35(14):4649-63. PubMed ID: 17591614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 10. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel isoform of iASPP and its interaction with p53.
    Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
    J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolutionary relationship between gene duplication and alternative splicing.
    Jin L; Kryukov K; Clemente JC; Komiyama T; Suzuki Y; Imanishi T; Ikeo K; Gojobori T
    Gene; 2008 Dec; 427(1-2):19-31. PubMed ID: 18835337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from a novel p53 isoform in zebrafish want to reel us in, but will we take the bait?
    Manfredi JJ
    Genes Dev; 2009 Feb; 23(3):261-4. PubMed ID: 19204113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain.
    Ding L; Mychaleckyj JC; Hegde AN
    Gene; 2007 Oct; 401(1-2):46-60. PubMed ID: 17707117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the p53 transcriptional activity.
    Liu G; Chen X
    J Cell Biochem; 2006 Feb; 97(3):448-58. PubMed ID: 16288459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript.
    Shu L; Yan W; Chen X
    Genes Dev; 2006 Nov; 20(21):2961-72. PubMed ID: 17050675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
    Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
    Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
    Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
    Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.
    Wei X; Xu H; Kufe D
    Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.